Skip to content
Screener
Q2 '26Q1 '26Q4 '25Q3 '25Q2 '25
-$4.27M-481%-$3.29M-363%-$1.43M+24.9%-$1.95M-26.8%-$735.21K+33.3%
——$1.28M+23.7%$1.04M-30.4%$3.03M+171%——
$77.87K-3.5%$106.84K+44.0%$172.16K+130%$81.26K+6.4%$80.69K+12.1%
$168.74K-80.0%$387.03K-90.1%$3.02K—$187.18K—$843.8K+199%
$38.28K+44.5%$0-100%$0-100%$23.79K+54.7%$26.49K+269%
-$1.93M—-$61.17K+95.0%-$3.07M—-$690.84K-464%$0+100%
——$61K-75.2%$0-100%$10.44K-89.4%$7.17K-94.7%
$5.24M—$0-100%——————
-$5.39M-3,472%-$763.3K+86.2%-$681.74K—-$386.88K—-$150.8K—
-$7.14M—-$437.45K+84.7%-$3.75M—-$890.54K———
$130.46K-84.0%$387.03K-89.9%$3.03K—$163.39K—$817.32K+195%

FAQ

How much cash does Cumberland Pharmaceuticals generate?
Cumberland Pharmaceuticals (CPIX) generated $746.0K in operating cash flow over the trailing twelve months.
What is Cumberland Pharmaceuticals's free cash flow?
After $62.1K of capital expenditures, Cumberland Pharmaceuticals's free cash flow was $683.9K over the trailing twelve months.
Where does Cumberland Pharmaceuticals's cash flow data come from?
Every line is extracted from Cumberland Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.